Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AN2 Therapeutics, Inc. - Common Stock
(NQ:
ANTX
)
10.38
-0.46 (-4.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,106
Open
10.91
Bid (Size)
7.500 (2)
Ask (Size)
16.70 (2)
Prev. Close
10.84
Today's Range
10.04 - 11.00
52wk Range
6.879 - 23.58
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
AN2 Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
AN2 Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+6.79%
+6.79%
1 Month
-15.33%
-15.33%
3 Month
+8.92%
+8.92%
6 Month
-7.32%
-7.32%
1 Year
-32.60%
-32.60%
More News
Read More
Top 5 Health Care Stocks That May Dip
January 27, 2023
Via
Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
November 14, 2022
Via
Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 09, 2022
From
AN2 Therapeutics, Inc.
Via
Globe NewsWire
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 02, 2022
From
AN2 Therapeutics, Inc.
Via
Globe NewsWire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
October 19, 2022
From
AN2 Therapeutics, Inc.
Via
Globe NewsWire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
October 12, 2022
Via
Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Via
Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
October 06, 2022
From
AN2 Therapeutics, Inc.
Via
Globe NewsWire
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
September 29, 2022
From
AN2 Therapeutics, Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Via
Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
August 30, 2022
Via
Benzinga
How Is The Market Feeling About AN2 Therapeutics?
August 15, 2022
Via
Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
August 12, 2022
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Via
Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
August 12, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 18, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 18, 2022
Via
InvestorPlace
Boeing And 24 Stocks Moving Premarket
July 18, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.